Abstract
We evaluated the effects of a lipid-lowering drug therapy with simvastatin, lovastatin, and pravastatin on the crystalline lens of the hypercholesterolemic rabbit. A threefold therapeutic dose was administered. Ocular examinations in mydriasis prior to treatment and after 14 and 30 weeks, respectively, were performed, including photographic documentation. Some degree of congenital lens opacities prior to treatment was frequently observed. No development of new cataracts could be proved during the study period.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
